TrialJAMA oncology2019

Disease-Free and Overall Survival Among Patients With Operable HER2-Positive Breast Cancer Treated With Sequential vs Concurrent Chemotherapy: The ACOSOG Z1041 (Alliance) Randomized Clinical Trial.

Aman U Buzdar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.